Novo Nordisk Seeks FDA and EMA Approval for Etavopivat to Treat Sickle Cell Disease

  The FDA New Drug Application (NDA) and EMA Marketing Authorization Application (MAA) submissions for etavopivat are based on da...

November 16, 2026 | Monday | News
Ascletis Pharma Submits US FDA IND Application for ASC30_39 Oral GLP-1 and Amylin Combination to Treat Obesity

ASC30_39 FDC, a once-daily oral fixed-dose combination (FDC) tablet of small molecule GLP-1R agonist ASC30 and small molecule selective amylin receptor ago...

November 12, 2026 | Thursday | News
Salvia Advances MySalvia Implantable Migraine Therapy with Pivotal RECLAIM-II Trial in the US

Biopharma Boardroom speaks with Hubert Martens, CEO of Salvia BioElectronics, about the development of the MySalvia System, an investigational implantable ...

November 02, 2026 | Monday | Interaction
AbbVie Submits FDA Application for Etentamig in Relapsed or Refractory Multiple Myeloma

–  Etentamig is a second-generation BCMA-directed bispecific antibody T-cell engager with a clinical profile and dosing schedule that can pote...

October 29, 2026 | Thursday | News
Cognition Therapeutics Reaches FDA Agreement on Phase 3 Zervimesine Trial for Lewy Body Dementia

Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical-stage company developing product candidates that treat neurodegenerativ...

October 23, 2026 | Friday | News
IBA Treats First Patient in Clinical Trial of ConformalFLASH Proton Therapy for Head and Neck Cancer

IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy so...

October 22, 2026 | Thursday | News
FDA Approves GSK and Ionis’ Hibsago for Chronic Hepatitis B Treatment

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) partner GSK announced that the U.S. Food and Drug Administration (FDA) has approved Hibsago (bepirovirsen) for t...

October 22, 2026 | Thursday | News
Alvotech Secures FDA Approval for New SIMLANDI Manufacturing Process, Doubling Batch Output

Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worl...

October 21, 2026 | Wednesday | News
FDA Approves Roche’s Enspryng for Adults with Thyroid Eye Disease

FDA approval based on Phase III SatraGO-1 and -2 studies, with SatraGO-2 demonstrating a significant reduction in eye bulging (proptosis) and improvement...

October 19, 2026 | Monday | News
FDA Grants Second Fast Track Designation to Marengo’s Invikafusp Alfa

New designation expands on first Fast Track Designation in TMB-H colorectal cancer and is supported by monotherapy responses across m...

October 16, 2026 | Friday | News
FDA Clears ArkBio’s AK0406 for Phase 2 Influenza Prevention Study

Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio")  announced that the U.S. Food and Drug Administration (FDA) has granted its investigational new dr...

October 14, 2026 | Wednesday | News
Foresee’s CAMCEVI Wins NMPA Approval in Advanced Prostate Cancer

Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") announced that it was notified by its licensing partner, Changchun GeneScience Pharmaceutical Co., Ltd. (...

October 13, 2026 | Tuesday | News
FDA Grants Fast Track Status to Leads Biolabs’ Opamtistomig in Biliary Tract Cancer

Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) announced that the U.S. Food and Drug Admin...

October 13, 2026 | Tuesday | News
FDA Approves Tecentriq Combination for Stage III dMMR Colon Cancer

FDA approval is based on results from the landmark Phase III ATOMIC study, published in The New England Journal of Medicine, which showed Tecentriq plu...

October 12, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close